University of Cambridge > Talks.cam > Computational and Systems Biology > To be confirmed

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹī¸ Information

To be confirmed

Download to your calendar using vCal

  • UserDaniel Crowther
  • ClockWednesday 15 February 2006, 14:00-15:00
  • HouseMR5, DAMTP.

If you have a question about this talk, please contact Stephen Eglen .

GlaxoSmithKline is one of the worlds leading pharmaceutical companies. In this talk I will aim to introduce the drug development process and highlight some of the ways in which bioinformatics is applied to the drug development process in GSK . The talk will focus on several key areas of impact, starting with target identification and validation including the application of structural analysis to protein engineering, describe the role of bioinformatics in handing human variation and finishing with at role bioinformatics plays in the discovery and application of biomarkers.

This talk is part of the Computational and Systems Biology series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Developments in Photoplethysmography Cambridge Research Seminar in Political Economy Engineering, Sir Arthur Marshall seminar room, IN2-09, second floor Inglis Building

Other talks

Chemical strategies for biomolecule functionalisation, and biomaterial conjugation Coming soon Complete and Submit Project Choice Forms Title to be confirmed Novel neuroimaging methods in Lewy body dementia C2D3 Computational Biology Annual Symposium 2026
 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity